The global infection surveillance solutions market size is
poised to reach USD 1.0 billion by 2026, according to a new report by Grand
View Research, Inc., progressing at a CAGR of 14.3% during the forecast period.
Improving healthcare settings worldwide coupled with advancements in healthcare
IT infrastructure is projected to play a pivotal role in the growth of the
market. Rising prevalence of healthcare associated infections (HAIs) has been
one of the critical factors driving the market.
According to HAI Prevalence Survey
conducted by the Center for Disease Control and Prevention (CDC), in 2014,
around 722,000 cases of HAIs were detected in the U.S hospitals alone.
Moreover, according to the California Department of Public Health (CDPH) in
2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition,
as per facts published by the European Commission (EC), around 25,000 people
die in European Union (EU) from antibiotic resistant bacteria. The figure is
expected to increase to 10 million deaths per year, if current infection trend
continues by 2050.
Rising collaboration and government
initiatives are also stimulating the growth of the market. For instance, in
January 2018, Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed
partnership agreement to introduce anti-microbial resistance stewardship
programs. The objective was to scale up AMR surveillance network in India.
Browse full research report on Infection Surveillance
Solutions Market: https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market
Further key findings from the report suggest:
- Surgical
site infections emerged as the most promising segment during the forecast
period owing to increasing number of surgeries being performed worldwide
- On
the basis of the product and services segment, the on-premise software
segment commanded the largest share in the market owing to its increased
usage
- North
America dominated the market in 2017. Government programs and rising
awareness about infection surveillance are facilitating the dominance of
this region during the forecast period
- Asia
Pacific is estimated to witness swift growth during the forecast period
due to increasing establishment of hospital chains and huge patient
population
- Few
of the key market players are Wolters Kluwer N.V; Gojo Industries; Becton;
Dickinson and Company; RL Solutions; Baxter International Inc.; Premier
Inc.; and Truven Health Analytics (An IBM Company).
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market/request/rs1
Grand View Research has segmented the global infection
surveillance solutions market based on infection type, product and services,
end use, and region:
Infection Surveillance Solutions Product and Services Outlook
(Revenue, USD Million, 2014 - 2026)
- Software
- On-premise
- Web-based
- Services
Infection Surveillance Solutions Infection Type Outlook (Revenue,
USD Million, 2014 - 2026)
- Surgical
Site Infections (SSI)
- Blood
Stream Infections (BSI)
- Urinary
Tract Infections (UTI)
- Others
Infection Surveillance Solutions End Use Outlook (Revenue, USD
Million, 2014 - 2026)
- Long
Term Care Facilities
- Hospitals
- Others
(Clinics, and Ambulatory Surgical Centers)
Infection Surveillance Solutions Regional Outlook (Revenue, USD
Million, 2014 - 2026)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
- Saudi
Arabia
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
No comments:
Post a Comment